Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 6 medicines
Anvisa · 2 medicines
FDA · 2 medicines
EMA · 1 medicine
AIFA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
31 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Cenobamate | United States | 100MG, 12.5MG, 200MG … | tablet | Tentative approval | Zenara Pharma Private LTD |
| Xcopri | United States | 100MG, 12.5MG, 150MG … | tablet | Marketed | SK Life |
| Ontozry 50 MG Comprimidos Recubiertos con Pelicula | Spain | 50 mg | comprimido recubierto con película | Marketed | Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An |
| Ontozry 50 MG Comprimidos Recubiertos con Pelicula | Spain | 50 mg | comprimido recubierto con película | Marketed | Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An |
| ONTOZRY 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | Spain | 100 mg | comprimido recubierto con película | Marketed | Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An |
| Ontozry 150 MG Comprimidos Recubiertos con Pelicula | Spain | 150 mg | comprimido recubierto con película | Marketed | Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An |
| ONTOZRY 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | Spain | 150 mg | comprimido recubierto con película | Marketed | Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An |
| ONTOZRY 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | Spain | 200 mg | comprimido recubierto con película | Marketed | Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An |
| ONTOZRY 12,5 mg COMPRIMIDOS + ONTOZRY 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | Spain | 12,5 mg + 25 mg | comprimido | Marketed | Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An |
| Ontozry | European Union | Authorised | Angelini Pharma S.p.A | ||
| Ontozry | Italy | Compressa rivestita con film | Authorised | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | |
| Ontozry 100mg, filmomhulde tablet | Netherlands | Filmomhulde tablet | Authorised | Angelini Pharma S.p.A | |
| Ontozry 12,5mg, filmomhulde tablet | Netherlands | Filmomhulde tablet | Authorised | Angelini Pharma S.p.A | |
| Ontozry 150mg, filmomhulde tablet | Netherlands | Filmomhulde tablet | Authorised | Angelini Pharma S.p.A | |
| Ontozry 200mg, filmomhulde tablet | Netherlands | Filmomhulde tablet | Authorised | Angelini Pharma S.p.A | |
| Ontozry 25mg, filmomhulde tablet | Netherlands | Filmomhulde tablet | Authorised | Angelini Pharma S.p.A | |
| Ontozry 50mg, filmomhulde tablet | Netherlands | Filmomhulde tablet | Authorised | Angelini Pharma S.p.A | |
| Xcopri | Canada | 50 MG + 100 MG | Kit, Tablet | Marketed | Knight Therapeutics INC. |
| Xcopri | Canada | 100 MG | Tablet | Marketed | Knight Therapeutics INC. |
| Xcopri | Canada | 150 MG | Tablet | Marketed | Knight Therapeutics INC. |
| Xcopri | Canada | 12.5 MG + 25 MG | Kit, Tablet | Marketed | Knight Therapeutics INC. |
| Xcopri | Canada | 12.5 MG | Tablet | Marketed | Knight Therapeutics INC. |
| Xcopri | Canada | 200 MG | Tablet | Marketed | Knight Therapeutics INC. |
| Xcopri | Canada | 50 MG | Tablet | Marketed | Knight Therapeutics INC. |
| Xcopri | Canada | 25 MG | Tablet | Marketed | Knight Therapeutics INC. |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, EMA, FDA, HALMED and Health Canada. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
